[1] [2] As a peptide-based prescription medicine, semaglutide requires careful handling to maintain its structural integrity and clinical efficacy
Seeking to amend the federal Food, Drug, and Cosmetic Act (FDCA), the bills sponsors frame the proposed legislation as essential to protect patients from untested, unapproved, and potentially dangerous mass compounded drugs. The bill was immediately referred to the House Committee on Energy and Commerce
A Complete Protocol for Sub-Standard Dosing How Do You Microdose Semaglutide
GLP-1 Weight Management Progress: Timeline and Expectations GLP-1-based treatments, such as compounded semaglutide, are used as part of supervised wellness programs
Compounded products are not FDA-approved, and the FDA has not evaluated them for safety, efficacy, or quality